Shuntao Wang

626 total citations
33 papers, 498 citations indexed

About

Shuntao Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Shuntao Wang has authored 33 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Shuntao Wang's work include Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (8 papers) and BRCA gene mutations in cancer (6 papers). Shuntao Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (8 papers) and BRCA gene mutations in cancer (6 papers). Shuntao Wang collaborates with scholars based in China and United States. Shuntao Wang's co-authors include Zeming Liu, Chunping Liu, Tao Huang, Wen Zeng, Tianwen Chen, Mingzhu Chen, Qinqin Huang, Tao Huang, Yawen Guo and Yusufu Maimaiti and has published in prestigious journals such as Scientific Reports, Medicine and Sustainability.

In The Last Decade

Shuntao Wang

33 papers receiving 487 citations

Peers

Shuntao Wang
Jinmiao Qu China
Norimasa Koike Japan
Chiaki Komine Japan
Hirotake Komatsu United States
Jatuporn Sujjitjoon Thailand
Kagenori Ito Japan
Pingping Xiang China
Ngoc-Quynh-Nhu Nguyen Belgium
Miki Abe Japan
Endong Chen China
Jinmiao Qu China
Shuntao Wang
Citations per year, relative to Shuntao Wang Shuntao Wang (= 1×) peers Jinmiao Qu

Countries citing papers authored by Shuntao Wang

Since Specialization
Citations

This map shows the geographic impact of Shuntao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuntao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuntao Wang more than expected).

Fields of papers citing papers by Shuntao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuntao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuntao Wang. The network helps show where Shuntao Wang may publish in the future.

Co-authorship network of co-authors of Shuntao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuntao Wang. A scholar is included among the top collaborators of Shuntao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuntao Wang. Shuntao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maimaiti, Yusufu, et al.. (2022). CircFAM64A enhances cellular processes in triple‐negative breast cancer by targeting the miR‐149‐5p/CDT1 axis. Environmental Toxicology. 37(5). 1081–1092. 12 indexed citations
3.
Hu, Jin, Xia Xu, Shuntao Wang, et al.. (2022). Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery. Frontiers in Oncology. 12. 896942–896942. 4 indexed citations
4.
Wang, Shuntao, et al.. (2022). Injectable Hydrogel System for Camptothecin Initiated Nanocatalytic Tumor Therapy With High Performance. Frontiers in Oncology. 12. 904960–904960. 5 indexed citations
5.
Wang, Shuntao, Ning Zeng, Qi Zhang, Mingzhu Chen, & Qinqin Huang. (2022). Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy. Frontiers in Oncology. 12. 888855–888855. 26 indexed citations
6.
Shu, Zhu, Shuntao Wang, Chunping Liu, Meng Lyu, & Qinqin Huang. (2022). Cu-Hemin Nanosheets and Indocyanine Green Co-Loaded Hydrogel for Photothermal Therapy and Amplified Photodynamic Therapy. Frontiers in Oncology. 12. 918416–918416. 12 indexed citations
7.
8.
Huang, Chunyu, Zeming Liu, Mingzhu Chen, et al.. (2021). Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy. Journal of Nanobiotechnology. 19(1). 457–457. 50 indexed citations
9.
Zeng, Wen, Chunping Liu, Shuntao Wang, Ziqi Wang, & Qinqin Huang. (2021). SnFe2O4 Nanozyme Based TME Improvement System for Anti-Cancer Combination Thermoradiotherapy. Frontiers in Oncology. 11. 768829–768829. 10 indexed citations
10.
Zhang, Yunke, et al.. (2021). LRP6 as a biomarker of poor prognosis of breast cancer. Gland Surgery. 10(8). 2414–2427. 9 indexed citations
11.
Hu, Jin, Huiqiong Zhang, Fang Dong, et al.. (2021). Metaplastic breast cancer: Treatment and prognosis by molecular subtype. Translational Oncology. 14(5). 101054–101054. 16 indexed citations
12.
Wu, Zhenghao, et al.. (2021). Reevaluation of Criteria and Establishment of Models for Total Thyroidectomy in Differentiated Thyroid Cancer. Frontiers in Oncology. 11. 691341–691341. 1 indexed citations
13.
Wang, Shuntao, et al.. (2019). Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis.. PubMed. 11(9). 6262–6270. 15 indexed citations
14.
15.
Wang, Juntao, et al.. (2018). Protective effects of dexmedetomidine on lung in rats with one‑lung ventilation. Experimental and Therapeutic Medicine. 17(1). 187–192. 15 indexed citations
16.
Liu, Chunping, Shuntao Wang, Wen Zeng, et al.. (2017). Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis. Scientific Reports. 7(1). 1846–1846. 25 indexed citations
17.
Liu, Zeming, Wen Zeng, Chunping Liu, et al.. (2017). Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study. World Journal of Surgical Oncology. 15(1). 32–32. 40 indexed citations
18.
Zhao, Qiuyang, Zhi Li, Shuntao Wang, et al.. (2017). Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma). Oncotarget. 8(60). 101362–101371. 12 indexed citations
19.
Liu, Chunping, Tianwen Chen, Wen Zeng, et al.. (2017). Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis. Scientific Reports. 7(1). 11412–11412. 45 indexed citations
20.
Shi, Lan, et al.. (2013). Treatment for papillary thyroid microcarcinoma. Współczesna Onkologia. 1(1). 20–23. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinmiao Qu Breakdown of academic impact, for papers by Norimasa Koike Breakdown of academic impact, for papers by Chiaki Komine Breakdown of academic impact, for papers by Hirotake Komatsu Breakdown of academic impact, for papers by Jatuporn Sujjitjoon Breakdown of academic impact, for papers by Kagenori Ito Breakdown of academic impact, for papers by Pingping Xiang Breakdown of academic impact, for papers by Ngoc-Quynh-Nhu Nguyen Breakdown of academic impact, for papers by Miki Abe Breakdown of academic impact, for papers by Endong Chen
Rankless by CCL
2026